Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    PLEUROPULMONARY BLASTOMA
Show Display Options
Rank Status Study
1 Recruiting International Pleuropulmonary Blastoma (PPB) Treatment and Biology Registry
Condition: Pleuropulmonary Blastoma
Interventions: Drug: Vincristine;   Drug: Dactinomycin;   Drug: Cyclophosphamide;   Drug: Ifosfamide;   Drug: Doxorubicin
2 Recruiting DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Ovarian Sertoli-Leydig Cell Tumors;   Ocular Medulloepithelioma;   Nasal Chondromesenchymal Hamartoma
Intervention:
3 Recruiting Elucidating the Genetic Basis of the Pleuropulmonary Blastoma (PPB) Familial Cancer Syndrome
Conditions: Pleuropulmonary Blastoma;   Cystic Nephroma;   Sertoli-Leydig Cell Tumor of Ovary;   Medulloepithelioma;   Embryonal Rhabdomyosarcoma of Cervix
Intervention:
4 Unknown  Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
Conditions: Brain and Central Nervous System Tumors;   Hereditary Wilms Tumor;   Kidney Cancer;   Liver Cancer;   Neuroblastoma;   Pleuropulmonary Blastoma;   Sarcoma
Interventions: Genetic: DNA analysis;   Genetic: cytogenetic analysis;   Genetic: gene expression analysis;   Genetic: gene rearrangement analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: laboratory biomarker analysis;   Other: medical chart review

Indicates status has not been verified in more than two years